• Professor James Chalmers, MBChB, PhD, FRCPE, FERS joins MCC Therapeutics Scientific Advisory Board

    Published On: September 13, 2026

  • Presentation at the European Respiratory Society 2026

    Published On: September 2, 2026

  • MCC Therapeutics, Inc. will present Phase 1 Clinical Results of MCCSA2 at the World Bronchiectasis Conference (WBC2026) in Hanover, Germany

    Published On: June 24, 2026

  • MCC Therapeutics announces the Publication of its Scientists’ Paper in the Journal of Clinical Investigation

    Published On: June 5, 2026

  • New hope from old drugs for cystic fibrosis: startup explores combination therapy

    Published On: October 7, 2025